Yiqun Han

9PUBLICATIONS
14CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 17, 2023
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer.

Yiqun Han, Jiayu Wang, Tao Sun

|Feb 25, 2023
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

Zhijun Li, Yiqun Han, Jiayu Wang

|Dec 23, 2022
Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis.

Jiani Wang, Yiqun Han, Jiayu Wang

|Jul 27, 2022
Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody-Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis.

Yan Wang, Hangcheng Xu, Yiqun Han

|May 22, 2022
Clinicopathological characteristics and prognosis of microinvasive breast cancer: A population-based analysis.

Hangcheng Xu, Yiqun Han, Yun Wu

|Oct 16, 2021
Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based Analysis.

Yiqun Han, Jiayu Wang, Zijing Wang

Pageof 2

Frequent Collaborators

4 joint publications

Binghe Xu

3 joint publications

Jiayu Wang

2 joint publications

Jiayu Wang

2 joint publications

Binghe Xu